Perrigo
FDA advisory committee votes in favour of OTC contraceptive pill
May 11, 2023Medical Communications Contraception, FDA, OTC, Perrigo, contraception
Perrigo Company has announced that the US Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, …
Perrigo name new head of its combined UK and Ireland business
April 26, 2016Sales and Marketing Ireland, Perrigo, UK, lister, neil, new head
Perrigo has named Neil Lister as the head of its newly-combined UK and Ireland business. The manufacturer and distributor of …
Perrigo rejects $26 billion hostile Mylan takeover bid
November 13, 2015Medical Communications, Sales and Marketing Mylan, Perrigo, mergers and acquisitions
Perrigo has rejected Mylan’s hostile $26 billion bid after a 60% majority of shareholders were unconvinced by the terms by …
Perrigo buys OTC products from GSK
June 3, 2015Sales and Marketing GSK, GlaxoSmithKline, Mylan, Perrigo, Teva, brett wells
In an all-cash move with no financial details disclosed Perrigo is buying a portfolio of leading over-the-counter products from GlaxoSmithKline. …
Teva forges ahead with Mylan pursuit
May 6, 2015Sales and Marketing Mylan, Perrigo, Teva, generics
Teva has reinforced its commitment to buy Mylan despite previous rejection and only days after Mylan upped its own bid …
Perrigo bats away raised Mylan bid
April 30, 2015Sales and Marketing Mylan, Perrigo, Teva, Vigodman, merger
Perrigo has rejected an updated $34.1 billion takeover bid from Mylan, whilst Teva has also written an open letter in …
M&A drama continues as Mylan rejects Teva
April 28, 2015Sales and Marketing M&A, MA, Mylan, Perrigo, Teva, bids, generics, takeovers
Mylan has firmly rejected Teva’s acquisition bid, even though its own bid for Irish firm Perrigo has also been turned …
Teva moves to buy Mylan
April 21, 2015Research and Development, Sales and Marketing India, Mylan, Perrigo, Teva, US, Vigodman, generics, israel, merger
Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …
Perrigo acquires Omega for $4.5 billion
November 7, 2014Manufacturing and Production, Sales and Marketing Actavis, Boehringer Ingelheim, Boehringer Ingelheim., Elan, Perrigo, Sanofi, omega
In a deal worth $4.5 billion Perrigo has announced the acquisition of over-the-counter (OTC) drugmaker Omega. This places the Irish …
Perrigo pays $8.6 billion for Elan
July 30, 2013Research and Development, Sales and Marketing Elan, Perrigo, Tysabri
Generics firm Perrigo has snapped up Ireland-based Elan in a multi-billion dollar deal, ending a bitter takeover battle that has …
Perrigo buys Rosemont for £180 million
February 12, 2013Manufacturing and Production Perrigo, Rosemont
UK-based Rosemont Pharmaceuticals has been sold by its private equity owner to Perrigo of the US in a £180 million …
Pharma manufacturing news in brief
April 14, 2011Manufacturing and Production Cangene, Chirotech, Grand River Aseptic Manufacturing, Perrigo, West Pharmaceutical Services
India’s Dr Reddy’s Laboratories has opened a new headquarters for its UK subsidiary ChiroTech, along with a new purpose-built laboratory …
Perrigo plans ‘massive transformation’ of API production
August 26, 2009Manufacturing and Production India, Perrigo
Pharmaceutical manufacturer Perrigo has taken a majority stake in Vedants Drugs and Fine Chemicals in a move that will shift …
Latest content
Five Facts about cardiovascular disease
